Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
JACC Cardiovasc Imaging ; 17(4): 411-424, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38300202

RESUMO

BACKGROUND: Imaging with late gadolinium enhancement (LGE) magnetic resonance (MR) and 18F-fluorodeoxyglucose (18F-FDG) PET allows complementary assessment of myocardial injury and disease activity and has shown promise for improved characterization of active cardiac sarcoidosis (CS) based on the combined positive imaging outcome, MR(+)PET(+). OBJECTIVES: This study aims to evaluate qualitative and quantitative assessments of hybrid MR/PET imaging in CS and to evaluate its association with cardiac-related outcomes. METHODS: A total of 148 patients with suspected CS underwent hybrid MR/PET imaging. Patients were classified based on the presence/absence of LGE (MR+/MR-), presence/absence of 18F-FDG (PET+/PET-), and pattern of 18F-FDG uptake (focal/diffuse) into the following categories: MR(+)PET(+)FOCAL, MR(+)PET(+)DIFFUSE, MR(+)PET(-), MR(-)PET(+)FOCAL, MR(-)PET(+)DIFFUSE, MR(-)PET(-). Further analysis classified MR positivity based on %LGE exceeding 5.7% as MR(+/-)5.7%. Quantitative values of standard uptake value, target-to-background ratio, target-to-normal-myocardium ratio (TNMRmax), and T2 were measured. The primary clinical endpoint was met by the occurrence of cardiac arrest, ventricular tachycardia, or secondary prevention implantable cardioverter-defibrillator (ICD) before the end of the study. The secondary endpoint was met by any of the primary endpoint criteria plus heart failure or heart block. MR/PET imaging results were compared between those meeting or not meeting the clinical endpoints. RESULTS: Patients designated MR(+)5.7%PET(+)FOCAL had increased odds of meeting the primary clinical endpoint compared to those with all other imaging classifications (unadjusted OR: 9.2 [95% CI: 3.0-28.7]; P = 0.0001), which was higher than the odds based on MR or PET alone. TNMRmax achieved an area under the receiver-operating characteristic curve of 0.90 for separating MR(+)PET(+)FOCAL from non-MR(+)PET(+)FOCAL, and 0.77 for separating those reaching the clinical endpoint from those not reaching the clinical endpoint. CONCLUSIONS: Hybrid MR/PET image-based classification of CS was statistically associated with clinical outcomes in CS. TNMRmax had modest sensitivity and specificity for quantifying the imaging-based classification MR(+)PET(+)FOCAL and was associated with outcomes. Use of combined MR and PET image-based classification may have use in prognostication and treatment management in CS.


Assuntos
Cardiomiopatias , Miocardite , Sarcoidose , Humanos , Fluordesoxiglucose F18 , Cardiomiopatias/diagnóstico por imagem , Cardiomiopatias/terapia , Cardiomiopatias/complicações , Meios de Contraste , Compostos Radiofarmacêuticos , Valor Preditivo dos Testes , Gadolínio , Tomografia por Emissão de Pósitrons/métodos , Imageamento por Ressonância Magnética/métodos , Miocardite/complicações , Espectroscopia de Ressonância Magnética , Sarcoidose/diagnóstico por imagem , Sarcoidose/terapia , Sarcoidose/complicações
2.
Respir Res ; 24(1): 23, 2023 Jan 21.
Artigo em Inglês | MEDLINE | ID: mdl-36681813

RESUMO

BACKGROUND: Low-dose spiral computed tomography (LDCT) may not lead to a clear treatment path when small to intermediate-sized lung nodules are identified. We have combined flow cytometry and machine learning to develop a sputum-based test (CyPath Lung) that can assist physicians in decision-making in such cases. METHODS: Single cell suspensions prepared from induced sputum samples collected over three consecutive days were labeled with a viability dye to exclude dead cells, antibodies to distinguish cell types, and a porphyrin to label cancer-associated cells. The labeled cell suspension was run on a flow cytometer and the data collected. An analysis pipeline combining automated flow cytometry data processing with machine learning was developed to distinguish cancer from non-cancer samples from 150 patients at high risk of whom 28 had lung cancer. Flow data and patient features were evaluated to identify predictors of lung cancer. Random training and test sets were chosen to evaluate predictive variables iteratively until a robust model was identified. The final model was tested on a second, independent group of 32 samples, including six samples from patients diagnosed with lung cancer. RESULTS: Automated analysis combined with machine learning resulted in a predictive model that achieved an area under the ROC curve (AUC) of 0.89 (95% CI 0.83-0.89). The sensitivity and specificity were 82% and 88%, respectively, and the negative and positive predictive values 96% and 61%, respectively. Importantly, the test was 92% sensitive and 87% specific in cases when nodules were < 20 mm (AUC of 0.94; 95% CI 0.89-0.99). Testing of the model on an independent second set of samples showed an AUC of 0.85 (95% CI 0.71-0.98) with an 83% sensitivity, 77% specificity, 95% negative predictive value and 45% positive predictive value. The model is robust to differences in sample processing and disease state. CONCLUSION: CyPath Lung correctly classifies samples as cancer or non-cancer with high accuracy, including from participants at different disease stages and with nodules < 20 mm in diameter. This test is intended for use after lung cancer screening to improve early-stage lung cancer diagnosis. Trial registration ClinicalTrials.gov ID: NCT03457415; March 7, 2018.


Assuntos
Neoplasias Pulmonares , Humanos , Detecção Precoce de Câncer/métodos , Citometria de Fluxo , Pulmão , Neoplasias Pulmonares/diagnóstico por imagem , Aprendizado de Máquina , Escarro
3.
PLoS One ; 17(8): e0272069, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35976857

RESUMO

Low dose computed tomography (LDCT) is the standard of care for lung cancer screening in the United States (US). LDCT has a sensitivity of 93.8% but its specificity of 73.4% leads to potentially harmful follow-up procedures in patients without lung cancer. Thus, there is a need for additional assays with high accuracy that can be used as an adjunct to LDCT to diagnose lung cancer. Sputum is a biological fluid that can be obtained non-invasively and can be dissociated to release its cellular contents, providing a snapshot of the lung environment. We obtained sputum from current and former smokers with a 30+ pack-year smoking history and who were either confirmed to have lung cancer or at high risk of developing the disease. Dissociated sputum cells were counted, viability determined, and labeled with a panel of markers to separate leukocytes from non-leukocytes. After excluding debris and dead cells, including squamous epithelial cells, we identified reproducible population signatures and confirmed the samples' lung origin. In addition to leukocyte and epithelial-specific fluorescent antibodies, we used the highly fluorescent meso-tetra(4-carboxyphenyl) porphyrin (TCPP), known to preferentially stain cancer (associated) cells. We looked for differences in cell characteristics, population size and fluorescence intensity that could be useful in distinguishing cancer samples from high-risk samples. We present our data demonstrating the feasibility of a flow cytometry platform to analyze sputum in a high-throughput and standardized matter for the diagnosis of lung cancer.


Assuntos
Neoplasias Pulmonares , Escarro , Detecção Precoce de Câncer/métodos , Citometria de Fluxo , Humanos , Pulmão/diagnóstico por imagem , Pulmão/patologia , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/patologia , Estados Unidos
5.
Ann Nucl Med ; 22(3): 165-70, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18498030

RESUMO

OBJECTIVE: To assess the diagnostic value of fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) using standard uptake values (SUV) in the differential diagnoses of indeterminate pulmonary nodules. Specifically, we assessed the probability of malignancy for various SUV ranges, and compared the diagnostic efficacy of SUV with and without correction for partial volume effects on the basis of lesion size. METHODS: The FDG-PET scans performed on 158 patients with biopsy-proven pulmonary lesions seen on computed tomography (CT) scan were retrospectively reviewed. Histopathological confirmation was obtained to establish the diagnosis of the lesions. A region of interest (ROI) was drawn for each lesion, and FDG uptake was quantified (SUV(raw)). The SUV(raw) values were normalized for the "size" of the pulmonary lesions measured on CT (SUV(size)). Sensitivity and specificity of FDG-PET for pulmonary lesions <2 cm in diameter or > or =2 cm in diameter were determined at SUV cutoff values of 2.5. The areas under the receiver-operating characteristic (ROC) curve for SUV(raw) and SUV(size) regarding the presence of malignancy were compared for statistical differences. The frequency of malignant lesions for each range of SUVs was obtained to produce the probability of cancer (POC). RESULTS: The mean SUV(raw) was 3.17 +/- 2.76 and 9.18 +/- 6.72 for benign and malignant lesions, respectively. When a SUV(raw) value of 2.5 was used as a cutoff, sensitivity and specificity were 89% and 51%, respectively, for all lesion sizes. The sensitivity and specificity at a cutoff SUV(raw) of 2.5 for lesions less than 2 cm in diameter were 75% and 72%, respectively, and 92% and 41% for lesions 2 cm or greater, respectively. The sensitivity and specificity at a cutoff SUV(size) of 2.5 were 88% and 42%, respectively. The area under the ROC curves for SUV(raw) and SUV(size) was 0.816 and 0.743, respectively (P value 0.034). When the SUV(raw) was divided into three groups, the probability of malignancy was 26% when the SUV(raw) was <2, 57% for 2 < or = SUV(raw) < 6, and 89% for SUV(raw) > or = 6. CONCLUSIONS: The FDG-PET is a reasonably accurate and useful tool for characterizing the nature of indeterminate pulmonary lesions, although the specificity was not as high as that reported in the literature, probably owing in part to our patient population and selection bias. Our data suggest that reporting the results of PET studies as a probability rather than as positive or negative for malignancy would be more useful for further management decision making. Correction of SUVs for tumor size did not improve accuracy.


Assuntos
Neoplasias Pulmonares/diagnóstico por imagem , Tomografia por Emissão de Pósitrons , Nódulo Pulmonar Solitário/classificação , Nódulo Pulmonar Solitário/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Ensaios Clínicos como Assunto , Estudos de Coortes , Diagnóstico Diferencial , Feminino , Fluordesoxiglucose F18/farmacocinética , Humanos , Interpretação de Imagem Assistida por Computador , Neoplasias Pulmonares/patologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Probabilidade , Curva ROC , Compostos Radiofarmacêuticos/farmacocinética
6.
Sarcoidosis Vasc Diffuse Lung Dis ; 22(2): 147-53, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16053031

RESUMO

AIM: To assess lung involvement and the association of demographic and psychosocial factors with respiratory health in 736 persons with sarcoidosis at enrollment in A Case Control Etiologic Study of Sarcoidosis (ACCESS). METHODS: 736 patients with biopsy diagnosis of sarcoidosis within 6 months of enrollment were studied at 10 US centers. Lung involvement was evaluated by chest radiography, spirometry and dyspnea questionnaire. Demographics, number of involved extrathoracic organ systems, comorbidities, and health-related quality of life (HRQL) were assessed. RESULTS: 95% of patients had lung involvement. 8% were Scadding Stage 0, 40% I, 37% II, 10% III, and 5% IV 51% reported dyspnea. Increasing radiographic lung stage was associated with decreasing Forced Vital Capacity (FVC) (p < 0.01). Patients with higher stages had more airways obstruction and dyspnea. 46% of cases and 27% of controls had Center for Epidemiologic Studies Depression Scale (CES-D) scores of 9 or greater, (p < 0.001). Age > or = 40, African-American race, body mass index > or = 30kg/m2, and CES-D scores > 9 were associated with decreased FVC and greater dyspnea. Impaired spirometry and greater dyspnea were associated with poorer quality of life. CONCLUSION: A "global" approach to the sarcoidosis patient, including careful assessment of dyspnea and health related quality of life, as well as of lung function and radiographic changes, and any extrathoracic involvement, is important, not only in management of the individual patient, but should also prove beneficial in assessing outcomes in clinical trials in the future.


Assuntos
Testes Psicológicos , Qualidade de Vida , Sarcoidose Pulmonar , Adulto , Negro ou Afro-Americano/etnologia , Biópsia , Estudos de Casos e Controles , Depressão/diagnóstico , Depressão/epidemiologia , Depressão/psicologia , Dispneia/diagnóstico , Dispneia/epidemiologia , Dispneia/psicologia , Feminino , Humanos , Incidência , Masculino , Valor Preditivo dos Testes , Prognóstico , Radiografia Torácica , Sarcoidose Pulmonar/diagnóstico , Sarcoidose Pulmonar/epidemiologia , Sarcoidose Pulmonar/psicologia , Índice de Gravidade de Doença , Espirometria , Inquéritos e Questionários , Estados Unidos/epidemiologia
7.
J Occup Environ Med ; 47(3): 226-34, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15761318

RESUMO

OBJECTIVES: To determine whether specific occupations and industries may be associated with sarcoidosis. METHODS: A Case Control Etiologic Study of Sarcoidosis (ACCESS) obtained occupational and environmental histories on 706 newly diagnosed sarcoidosis cases and matched controls. We used Standard Industrial Classification (SIC) and Standard Occupational Classification (SOC) to assess occupational contributions to sarcoidosis risk. RESULTS: Univariable analysis identified elevated risk of sarcoidosis for workers with industrial organic dust exposures, especially in Caucasian workers. Workers for suppliers of building materials, hardware, and gardening materials were at an increased risk of sarcoidosis as were educators. Work providing childcare was negatively associated with sarcoidosis risk. Jobs with metal dust or metal fume exposures were negatively associated with sarcoidosis risk, especially in Caucasian workers. CONCLUSIONS: In this study, we found that exposures in particular occupational settings may contribute to sarcoidosis risk.


Assuntos
Descrição de Cargo , Ocupações , Sarcoidose/etiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Humanos , Indústrias , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Sarcoidose/epidemiologia
8.
Am J Respir Crit Care Med ; 170(12): 1324-30, 2004 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-15347561

RESUMO

Past research suggests that environmental factors may be associated with sarcoidosis risk. We conducted a case control study to test a priori hypotheses that environmental and occupational exposures are associated with sarcoidosis. Ten centers recruited 706 newly diagnosed patients with sarcoidosis and an equal number of age-, race-, and sex-matched control subjects. Interviewers administered questionnaires containing questions regarding occupational and nonoccupational exposures that we assessed in univariable and multivariable analyses. We observed positive associations between sarcoidosis and specific occupations (e.g., agricultural employment, odds ratio [OR] 1.46, confidence interval [CI] 1.13-1.89), exposures (e.g., insecticides at work, OR 1.52, CI 1.14-2.04, and work environments with mold/mildew exposures [environments with possible exposures to microbial bioaerosols], OR 1.61, CI 1.13-2.31). A history of ever smoking cigarettes was less frequent among cases than control subjects (OR 0.62, CI 0.50-0.77). In multivariable modeling, we observed elevated ORs for work in areas with musty odors (OR 1.62, CI 1.24-2.11) and with occupational exposure to insecticides (OR 1.61, CI 1.13-2.28), and a decreased OR related to ever smoking cigarettes (OR 0.65, CI 0.51-0.82). The study did not identify a single, predominant cause of sarcoidosis. We identified several exposures associated with sarcoidosis risk, including insecticides, agricultural employment, and microbial bioaerosols.


Assuntos
Exposição Ambiental/efeitos adversos , Exposição Ocupacional/efeitos adversos , Sarcoidose/etiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Fatores de Risco
9.
Sarcoidosis Vasc Diffuse Lung Dis ; 20(3): 204-11, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14620163

RESUMO

A cohort of 215 sarcoidosis patients from the ACCESS study underwent a clinical evaluation at study enrollment and two years later. Approximately 80% of subjects had an improved or stable FVC, FEV1, chest radiograph determined by Scadding stage, and dyspnea scale. African-Americans had less improvement in FVC than Caucasians (p = 0.04). Patients with erythema nodosum at presentation were more likely to have improvement in the chest radiograph at two-year follow-up (p = 0.007). Patients with a lower annual family income were more likely to worsen with respect to dyspnea (p = 0.01) and more likely to have new organ involvement at two-year follow-up (p = 0.045). The development of new organ involvement over the two year follow-up period was more common in African-Americans compared to Caucasians (p = 0.002) and more likely in those with extrapulmonary involvement at study entry (p = 0.003). There was an excellent concordance between changes in FVC and FEV1 over the two-year period. However, changes in FVC alone were inadequate to describe the change in pulmonary status of the patients, as changes in chest radiographic findings or the level of dyspnea did often but not always move in the same direction as FVC. In conclusion, data from this heterogeneous United States sarcoidosis population indicate that sarcoidosis tends to improve or remain stable over two years in the majority of patients. Several factors associated with improved or worse outcome over two years were identified.


Assuntos
Negro ou Afro-Americano , Sarcoidose/complicações , Sarcoidose/patologia , População Branca , Adulto , Estudos de Casos e Controles , Estudos de Coortes , Progressão da Doença , Dispneia/classificação , Dispneia/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Testes de Função Respiratória , Estados Unidos
10.
Mt Sinai J Med ; 69(5): 350-3, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12415330

RESUMO

We report a patient with tissue-proven sarcoidosis receiving adrenocorticosteroid medication, who developed an enlarging mediastinal mass. Transcutaneous needle biopsy of the mass yielded pus which grew Nocardia asteroides on culture. Pleural effusion, bronchoesophageal fistula and brain nocardia metastases occurred. All evidence of active infection cleared with sulfa therapy. An enlarging mass in a patient with sarcoidosis unresponsive to corticosteroid therapy should provoke studies for other causes of mediastinal disease, including opportunistic infections.


Assuntos
Anti-Inflamatórios/efeitos adversos , Doenças do Mediastino/etiologia , Nocardiose/etiologia , Infecções Oportunistas/etiologia , Prednisona/efeitos adversos , Sarcoidose/complicações , Adulto , Feminino , Humanos , Doenças do Mediastino/diagnóstico , Doenças do Mediastino/microbiologia , Nocardiose/diagnóstico , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/microbiologia , Sarcoidose/tratamento farmacológico
11.
Mt Sinai J Med ; 69(3): 113-20, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12035070

RESUMO

A 67-year-old woman with hypertension, diabetes, hypothyroidism and chronic renal failure reported to the hospital for her regularly scheduled hemodialysis, complaining of shortness of breath. Despite fluid removal during her hemodialysis, she remained tachypneic and developed stridor. She was admitted to the hospital for a work-up of a known mediastinal mass, thought to be a goiter. However, she deteriorated over the next several hours and expired. A post-mortem examination confirmed fatal pulmonary emboli. This case illustrates the fact that, while most patients with chronic renal failure are considered to be at low risk for pulmonary emboli, it is often not diagnosed when present. In this paper, we will review the epidemiological data supporting this notion, examine proposed pathophysiological mechanisms, and review the diagnostic approach that should be considered in the setting of chronic renal failure.


Assuntos
Dispneia/etiologia , Falência Renal Crônica/complicações , Embolia Pulmonar/etiologia , Idoso , Evolução Fatal , Feminino , Humanos , Falência Renal Crônica/fisiopatologia , Embolia Pulmonar/diagnóstico , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...